Spain – Various medicinal products – Suministro de los principios activos denominados "ODEVIXIBAT 1200 MCG" Y "LANREOTID
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín awarded a contract of undisclosed value to IPSEN PHARMA, S.A. for Construction & Public Works in May 2026 — one of 265 awards this buyer has made.
Winning supplier
IPSEN PHARMA, S.A.Contract description
Spain – Various medicinal products – Suministro de los principios activos denominados "ODEVIXIBAT 1200 MCG" Y "LANREOTIDA 60 MG IM SC" para el Hospital Universitario de Gran Canaria Dr. Negrín.
Related awards · Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
265 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-199904-2026ACJ, S.A.U.€698K23 Mar 2026 Construction
- ocds-ted-37645-2025PALEX MEDICAL, S.A.€666K20 Jan 2025 Construction
- ocds-ted-497865-2024GETINGE GROUP SPAIN, S.L.U.€583K20 Aug 2024 Professional Services
Other wins · IPSEN PHARMA, S.A.
33 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-237117-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€2.5M22 Apr 2024 Construction
- ocds-ted-108007-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.8M18 Feb 2025 Construction
- ocds-ted-367498-2025Dirección General de Planificación Económica€1.4M06 Jun 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín and IPSEN PHARMA, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back